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Crystal Structure of a Transition State Mimic
for Tdp1 Assembled from Vanadate, DNA,
and a Topoisomerase I-Derived Peptide
causes a hereditary neurological disorder called spinocer-
ebellar ataxia with axonal neuropathy (SCAN1) [9].
Sequence comparisons and structural studies have
shown that Tdp1 is a member of the phospholipase D
(PLD) superfamily [10, 11]. Enzymes in this superfamily
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Seattle, Washington 98195 and a type II restriction endonuclease [12–15]. PLD
superfamily enzymes catalyze phosphodiester bond
cleavage through a phosphoryl transfer mechanism
where the acceptor is either an alcohol or water. The
Summary similar chemistry for the members of the family appears
to derive from a pair of motifs (referred to as “HKD
Tyrosyl-DNA phosphodiesterase (Tdp1) is a member motifs”) where highly conserved histidine and lysine res-
of the phospholipase D superfamily and acts as a DNA idues in the sequence HxK are necessary for catalytic
repair enzyme that removes stalled topoisomerase I- activity [14, 16]. Structural studies have shown that pairs
DNA complexes by hydrolyzing the bond between a of HKD motifs come together to form a single active
tyrosine side chain and a DNA 3 phosphate. Despite site [11, 16, 17]. Biochemical studies indicate that PLD
the complexity of the substrate of this phosphodies- superfamily enzymes catalyze reactions via two sequen-
terase, vanadate succeeded in linking human Tdp1, tial SN2 nucleophilic attacks, the first of which leads to
a tyrosine-containing peptide, and a single-stranded formation of a covalent phosphohistidine intermediate,
DNA oligonucleotide into a quaternary complex that and the second of which cleaves the intermediate to
mimics the transition state for the first step of the yield the final products [10, 18–22].
catalytic reaction. The conformation of the bound sub- Human Tdp1 is a monomeric protein that consists of
strate mimic gives compelling evidence that the topo- two--domains that share similar topology, including
isomerase I-DNA complex must undergo extensive a conserved seven-stranded mixed parallel-antiparallel
modification prior to cleavage by Tdp1. The structure  sheet [11] (Figure 1A). The active site containing the
also illustrates that the use of vanadate as the central pairs of conserved histidine and lysine residues lies
moiety in high-order complexes has the potential to along a pseudo-2-fold axis of symmetry between the
be a general method for capturing protein-substrate two domains. Structures of Tdp1 complexed with vana-
interactions for phosphoryl transfer enzymes, even date and tungstate showed these transition metal oxo-
when the substrates are large, complicated, and un- anions to be covalently linked to His263, confirming this
usual. residue as the nucleophile in the first step of the catalytic
reaction [23]. The active site is centrally located in an
asymmetrical cleft that extends approximately 40 A˚Introduction
across the surface of the enzyme. On one side of the
active site, this narrow 8 A˚ wide cleft has a predomi-Tyrosyl-DNA phosphodiesterase (Tdp1) catalyzes the
nantly positively charged electrostatic surface potential.hydrolysis of a phosphodiester bond between a tyrosine
On the other side of the active site, the cleft widens into aside chain and a DNA 3 phosphate [1]. Such a linkage
semiconically shaped depression that is approximatelyis only known to occur in eukaryotic cells as part of
20 A˚ wide at the end distal to the active site and isthe transient covalent enzyme-DNA intermediate formed
lined with a mixture of both basic and acidic amino acidwhen a type IB DNA topoisomerase nicks double-
residues. The shape and charge distribution of thesestranded DNA. Stalled topoisomerase I-DNA covalent
substrate binding clefts, together with clues providedcomplexes can be induced by various forms of DNA
by the Tdp1-vanadate structure, led to the hypothesisdamage and by treatment with anticancer drugs such
that the narrow positively charged cleft binds the DNAas camptothecin [2–4]. In the yeast Saccharomyces ce-
moiety of the substrate and that the wider cleft bindsrevisiae, Tdp1 has been shown to be involved in the
the peptide moiety [11, 23].repair of this type of DNA damage, since Tdp1 mutants
The nucleic acid-protein substrate of Tdp1 is com-become hypersensitive to camptothecin in situations
plex. The native human topoisomerase I-DNA complexwhere alternative pathways for DNA repair involving the
consists of a 91 kDa protein covalently bound to acheckpoint gene RAD9 and the endonucleases RAD1
nicked, double-stranded DNA molecule. A crystal struc-and MUS81 are blocked [5–8]. These findings suggest
ture of a reconstituted human topoisomerase I cova-that inhibitors of Tdp1 may potentially be useful in com-
lently bound to double-stranded DNA shows that thebined drug therapy with camptothecin for treatment of
scissile phosphotyrosine bond is buried deep within thiscancers. The importance of human Tdp1 is also underlined
complex and would be inaccessible to Tdp1 (see Figureby the recent discovery of a mutation in the enzyme that
2A) [24]. Indeed, a complex containing a native form of
topoisomerase I is cleaved poorly if at all by human
Tdp1 (H.I. and J.J.C., unpublished results). It has been*Correspondence: hol@gouda.bmsc.washington.edu
Figure 1. The Structure of the Tdp1-Vanadate-Peptide-DNA Complex
(A) Ribbon diagram for the overall structure. Tdp1 is displayed as a ribbon structure with the N-terminal domain (residues 162–350) colored
blue and the C-terminal domain (residues 351–608) colored yellow, viewed down the pseudo-2-fold axis of symmetry between the domains.
His263, Lys265, His493, and Lys495 are displayed as ball-and-stick structures. The substrate analog is also displayed in ball-and-stick form
with the bonds of the peptide moiety in magenta, the vanadate in blue, and the DNA in purple.
(B) Difference electron density for the Tdp1-vanadate-peptide-DNA complex. Coloration is the same as in (A). The topoisomerase I-derived
peptide follows the numbering system of the full-length topoisomerase I enzyme. Contours represent the 2.5-sigma level in the initial Fo-Fc
electron density map calculated for the molecular replacement solution with apo-Tdp1 used as the search model. Figures 1, 2, and 3 were
created using RIBBONS [34].
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suggested that the topoisomerase I-DNA complex must
undergo modification or partial degradation prior to
cleavage of the phosphotyrosine bond by Tdp1 [1].
Several clues about the nature of the Tdp1 substrate
in vivo have recently emerged. Genetic studies in yeast
have indicated that Tdp1 may function subsequent to
the formation of the double-strand break that results
from collision of a replication fork with a stalled topo-
isomerase I [6]. Consistent with this hypothesis, yeast
Tdp1 has been shown to prefer substrates with a tyro-
sine residue at the 3 end of either single-stranded DNA
or blunt-ended duplexes over substrates with tyrosine
on the 3 end at a nick in the middle of a duplex [6].
Although a native topoisomerase I-DNA complex is not
a substrate for Tdp1, a complex of DNA and the isolated
6.3 kDa C-terminal domain of topoisomerase I that con-
tains the active tyrosine is cleaved (H.I. and J.J.C., un-
published results). Additional information about sub-
strates that can be accepted by Tdp1 comes from the
fact that in vitro experiments with human Tdp1 are rou-
tinely performed using a substrate called “12-pep,” a
fragment of the human topoisomerase I-DNA complex
consisting of a single-stranded 12-mer oligonucleotide
with a small trypsin-resistant peptide linked to the 3
end of the DNA via the active site tyrosine [10].
The ability of human Tdp1 to cleave the 12-pep sub-
strate, the shape of the putative DNA binding cleft, and
lessons learned from the study of Tdp1-vanadate crys-
tals suggested experiments to explore the feasibility of
215–634, colored gray) and the C-terminal domain (residues 713–
765, colored green) covalently bound to a cleaved 22-base pair DNA
duplex (colored blue) via Tyr723. Not shown is a 69-residue coiled-
coil domain present in the native enzyme that acts as a linker be-
tween the core subdomains and the C-terminal domain. Tyr723, the
catalytic residue that forms the phosphotyrosine intermediate, is
located in the C-terminal domain and is displayed as a green ball-
and-stick structure. The 1 to 6 residues of DNA on the 5 side
of the phosphotyrosine linkage (corresponding to the length of the
oligonucleotide used for crystallization with Tdp1) are colored
orange.
(B) Model of the “native” conformation of the Tdp1 substrate, as
observed in the crystal structure of a topoisomerase I-DNA covalent
complex. For clarity, all protein except for the eight residues corre-
sponding to the peptide moiety in the Tdp1-vandadate-peptide-
DNA cocrystal complex (green ball-and-stick structure) has been
removed, and the structure has been rotated slightly around the
DNA axis from the view in (A). Dotted lines extending form the N
and C termini of the peptide indicate that the actual size of the
peptide that eventually binds to Tdp1 in vivo is not known.
(C) Comparison of the observed structures of DNA and topoisomer-
ase I peptide from the native structure of the topoisomerase I-DNA
covalent complex [24] (orange and green) and the Tdp1-vanadate-
peptide-DNA complex (purple and magenta). The two structures are
superimposed at the 1 nucleotide. The curved arrow shows the
relative rotation of the peptide moiety from the conformation in the
native topoisomerase I-DNA complex to the conformation observed
bound to Tdp1. The conformation observed in the Tdp1 structure
could not be achieved without removal or significant structural re-
arrangement of the intact strand and the 3 end of the nicked strand
Figure 2. Comparison of the Topoisomerase I-DNA Covalent Com- of DNA in the topoisomerase I-DNA complex.
plex with the Peptide-Vanadate-DNA Substrate Mimic Bound to (D) The crystal structure of the Tdp1-vanadate-peptide-DNA com-
Tdp1 plex. This view preserves the orientation of the substrate mimic that
(A) The crystal structure of a human topoisomerase I-DNA covalent is displayed in (C). Tdp1 is depicted as a ribbon diagram with the
complex [24]. This model represents catalytically active “reconstitu- same color scheme as in Figure 1 and is viewed nearly perpendicular
ted topoisomerase I” that consists of core subdomains I–III (residues to the pseudo-2-fold axis of symmetry.
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inducing binding of a short peptide, a single strand of binding and transition state stabilization [10]. Linkage
to vanadate indicates that His263 is the attacking nu-DNA, and vanadate simultaneously in the active site
of Tdp1. By exploiting the versatile ligand binding prop- cleophile for the first step of the Tdp1 catalytic reaction.
Therefore, the peptide moiety occupying the apical posi-erties of vanadate, a quaternary complex that mimics
the transition state of the Tdp1-catalyzed reaction could tion opposite His263 represents the leaving group for
this step. In its equatorial location, the DNA strand repre-be obtained. The crystal structure of this quaternary
complex provides further insights into the catalytic sents the portion of the phosphodiester substrate that
would remain bound to Tdp1 via a covalent phosphohis-mechanism and substrate binding properties of Tdp1.
tidine linkage until hydrolysis of the phosphohistidine
intermediate occurs in the second step of the catalytic
Results and Discussion reaction. The DNA is bound in the narrow, positively
charged substrate binding groove, and the peptide is
The Quaternary Complex with Vanadate located in the wider substrate binding cleft (Figure 4),
In the previously determined crystal structure of Tdp1- confirming our earlier prediction concerning the orienta-
vanadate, a glycerol molecule from the cryoprotectant tion of the bound peptide and DNA moieties of the sub-
solution formed a cyclic diester complex with the vana- strate [23].
date moiety [23]. Attempts to cocrystallize Tdp1 with
vanadate and single-stranded oligonucleotides yielded
similar structures of vanadate-glycerol complexes when Substrate Binding Characteristics
The N-terminal five residues of the 8-mer peptide areglycerol was used as a cryoprotectant, but no DNA could
be seen in the electron density maps (D.R.D., unpub- visible in the electron density map (Figure 3B). The pep-
tide moiety of the quaternary complex occupies a smalllished results). Most likely, the formation of complexes
of Tdp1, vanadate, and substrates was hampered by portion of the wide substrate binding cleft, burying ap-
proximately 575 A˚2 of solvent-accessible surface areainterference from glycerol. Since the hydroxyl groups of
glycerol might have been competing with the 3OH of but makes only three direct hydrogen bonding contacts
with Tdp1. Lys720 of the topoisomerase I-derived pep-the DNA oligonucleotides as ligands for vanadate, sub-
sequent cocrystallization experiments employed a cryo- tide contacts the carboxylate side chain of Asp230, the
backbone nitrogen of Phe206, and the phenolic oxygenprotectant lacking free hydroxyl groups, PEG 250 di-
methyl ether. of Tyr204 (Figure 3B). However, Tyr204 and Asp230 are
not conserved among Tdp1 orthologs. The conformationBy using precise cocrystallization and cryoprotection
protocols, enzyme, vanadate, peptide, and DNA were of the peptide, as seen in our quaternary complex, is
significantly different from the conformation of the corre-induced to self-assemble around a central vanadate
moiety in the active site of Tdp1. The peptide (NH2-Lys- sponding region found in the crystal structures of human
topoisomerase I. Both the N and C termini of the topo-Leu-Asn-Tyr-Leu-Asp-Pro-Arg-COOH) corresponds to
residues 720–727 of human topoisomerase I, a segment isomerase I-derived peptide are oriented in such a way
that additional stretches of polypeptide could be ac-of the C-terminal domain containing the active site tyro-
sine residue, Tyr723. The DNA oligonucleotide used was commodated with little or no conformational change by
either the peptide or Tdp1. Nevertheless, the structurea 6-mer (5-AGAGTT-3) derived from the DNA sequence
in the Tdp1 substrate 12-pep. Along with vanadate, the of the topoisomerase I-derived peptide observed here
may not reflect the conformation present in the naturalpeptide and DNA cocrystallize with Tdp1 in the same
space group with similar unit cell dimensions as Tdp1- Tdp1 substrate, where the peptide moiety may be sub-
stantially larger. Surprisingly, Tyr723 makes no contactsvanadate and Tdp1-tungstate crystals [23]. The struc-
ture of the quaternary complex was solved by molecular with Tdp1 whatsoever, aside from the covalent linkage
to the enzyme via vanadate. This observed lack of speci-replacement at a resolution of 2.3 A˚ (Figure 1). The ensu-
ing difference electron density map clearly indicated ficity for tyrosine is consistent with a recent report that
Tdp1 is also capable of removing glycolate from 3-that a covalent complex of Tdp1, vanadate, peptide,
and ssDNA had been obtained (Figure 1B). phosphoglycolate on DNA [25] and suggests that Tdp1
may have a broad specificity for a variety of blocked 3The vanadate at the center of the quaternary complex
adopts a trigonal bipyramidal configuration that mimics DNA termini.
In the structure, three nucleotides of the 6-mer DNAthe transition state of an SN2 nucleophilic attack on
phosphate (Figures 1B and 3A). One apical ligand is at the 3 end of the oligonucleotide are visible in the
electron density map, representing the 1 to 3 posi-contributed by the N2 atom of His263 of Tdp1, and the
other apical ligand is the oxygen atom of the tyrosine tions according to the topoisomerase I nomenclature,
although the purine base moiety of 3G is disordered.side chain of the topoisomerase I-derived peptide. One
of the three equatorial oxygen ligands to vanadate is These three nucleotides extend nearly to the end of the
narrow, positively charged substrate binding cleft andcontributed by the 3 hydroxyl of the DNA oligonucleo-
tide. The remaining two equatorial oxygen ligands repre- bury approximately 400 A˚2 of solvent-accessible surface
area (Figure 4). Out of ten direct and water-mediatedsent the nonbridging oxygens of the phosphodiester
substrate, and each one is within hydrogen-bonding hydrogen bonds between Tdp1 and DNA, all but one
contact phosphate groups (Figure 3C). The remainingdistance of the N atom of a lysine and the N2 atom
of an asparagine (Figure 3A). These residues, Lys265, hydrogen bond is between the phenolic oxygen of
Tyr204 of Tdp1 and the O2 atom of the thymine baseAsn283, Lys495, and Asn516, are conserved among
Tdp1 orthologs and are likely important for substrate at the 1 position. Interestingly, the same nucleotide
Figure 3. Hydrogen Bonding Contacts between Tdp1 and the Vanadate-Peptide-DNA Substrate Transition State Analog
Tdp1, peptide, and DNA are colored as in Figure 1A, with the vanadate moiety in green and hydrogen bonds indicated by dashed lines.
Residues 232–242 of Tdp1 have been omitted for clarity. Hydrogen bonds to the vanadate moiety are displayed in (A), hydrogen bonds to
the peptide moiety are displayed in (B), and hydrogen bonds to the DNA moiety in (C).
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human enzyme [10, 23]. The identities and functions
of the key residues in this expanded Tdp1 signature
sequence are presented in Table 1.
The overall conformation of the DNA bound to Tdp1
is irregular and extended and is elongated compared to
B-form DNA. Modeling studies indicate that canonical
duplex DNA is unlikely to bind to Tdp1 in the absence
of a conformational change in the nucleotides at the 3
end, since the backbone of a strand of DNA forming
Watson-Crick base pairs with nucleotides 1 to 3
would likely clash with loop 229–232 of Tdp1 (data not
shown). However, since phosphotyrosine at the 3 end
of a blunt-ended DNA duplex has been shown to be a
substrate for S. cerevisiae Tdp1 [6], the question re-
mains if and how human Tdp1 can accommodate dou-
ble-stranded DNA in its substrate binding groove. Given
the narrow DNA binding cleft observed in the native
enzyme [11] and the current quaternary complex, it
would appear that in order for human Tdp1 to remove
a topoisomerase I peptide from the end of duplex DNA,
a conformational change in either Tdp1 or the DNA mustFigure 4. Electrostatic Potential Surface of Tdp1
occur. Unpairing of the terminal few base pairs of theThe molecular surface is colored between 10kT (red) and 10kT
(blue) and was generated with the program GRASP [35]. The orienta- duplex may be sufficient to allow binding by Tdp1.
tion of the Tdp1 structure is the same as in Figure 1A. The peptide-
vanadate-DNA substrate mimic is displayed as a stick structure. Processing of the Topoisomerase I-DNA Complex
The yellow V indicates the position of the vanadate residue in the Is Required Prior to Tdp1 Cleavage
active site. The DNA moiety extends above the active site, bound
The conformation of the analog of the topoisomerasein the narrow, positively charged half of the substrate binding
I-DNA fragment bound to Tdp1 provides compelling evi-groove. The peptide moiety is located below the active site in a
relatively neutral portion of the wider substrate binding cleft. dence that the topoisomerase I-DNA complex must un-
dergo extensive structural changes such as proteolysis
and/or unfolding prior to cleavage by Tdp1 as suggested
oxygen atom is involved in the sole base-specific con- earlier by Yang et al. [1]. The relative conformations of
tact observed in the structures of human topoisomerase the peptide and DNA moieties in the crystal structure
I bound to DNA and possibly reflects the sequence pref- of a topoisomerase I-DNA covalent complex and in the
erence of the topoisomerase for a thymine base at the Tdp1 substrate binding clefts are remarkably different
1 position [26]. Otherwise, the relative lack of se- (Figure 2C). In the Tdp1 structure, the aromatic rings of
quence specificity in DNA binding by Tdp1 is to be ex- the tyrosine of the peptide and the base at the1 position
pected, since topoisomerase I has only weak sequence of the DNA are in proximity to one another, although too
specificity [27, 28]. Thus, stalled complexes between widely spaced to exhibit stacking interactions. This ar-
DNA and topoisomerase I could occur with a variety of rangement is in contrast to the conformation observed
different DNA sequences. in the covalent topoisomerase I-DNA structure, where
Surprisingly, most of the Tdp1-DNA contacts are with the tyrosine ring and the base of nucleotide 1 adopt
polar but not basic residues despite the fact that the a “trans” conformation about the central phosphate moi-
DNA binding cleft is positively charged. Phosphate bind- ety (Figure 2C). Remarkably, the conformation observed
ing sites containing serine appear to be a common motif for the peptide-vanadate-DNA substrate analog bound
among Tdp1 orthologs, as Ser400, Ser403, and Ser518 to Tdp1 could not be achieved in an intact topoisomer-
are conserved [10]. Notably, Ser400 and Ser518 are also ase I-DNA complex involving duplex DNA, because the
conserved in the only two other PLD superfamily mem- tyrosine would clash with the 5 end of the nicked strand
bers besides Tdp1 known to have a DNA substrate: a of DNA as seen in the topoisomerase I-DNA complex
nuclease from Salmonella and the BfiI restriction endo- (Figures 2B and 2C). This finding is in agreement with the
nuclease [11, 15]. Interestingly, the 5 phosphate of2T observation that the native 91 kDa topoisomerase I-DNA
occupies the same position that was identified as a low- complex is refractory to cleavage by Tdp1 (H.I. and J.J.C.,
occupancy tungstate binding site in the structure of unpublished results). Some significant rearrangement of
Tdp1-tungstate [23]. Another conserved residue is the topoisomerase I-DNA complex is therefore required
Phe259 (conserved in all known species except Schizo- in order for the substrate to adopt the conformation
saccharomyces pombe, where it is tryptophan), which observed in the Tdp1 quaternary complex. Removal or
is in position to intercalate between the bases at the 2 unpairing of the intact strand of DNA coupled with pro-
and 3 positions. Thus, Phe259, along with the con- teolytic degradation or unfolding of the core subdo-
served phosphate binding serine residues, expand the mains of topoisomerase I are possible mechanisms that
Tdp1 signature sequence that includes the pairs of HxK would allow the phosphodiester moiety enough confor-
sequences (His263, Lys265, His493, and Lys495) and mational flexibility to bind to Tdp1 in the manner dis-
other conserved residues in the active site, Thr281, played in the crystal structure of the quaternary
complex.Asn283, Asp288, Gln294, Asn516, and Glu538 in the
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Table 1. Conserved Residues in Tdp1 Orthologs and Their Function
Residue in Human Sequence Function
Phe259 (Trp in S. pombe) DNA binding
His263 Nucleophile in first step of catalytic reaction
Lys265 Substrate binding and transition state stabilization
Thr281 (Ser in S. cerevisiae) Orientation of Gln294
Asn283 Substrate binding and transition state stabilization
Asp288 (Glu in S. cerevisiae) Orientation of Gln294
Gln294 Orientation of His493
Ser400 DNA binding
Ser403 (Thr in T. brucei) DNA binding
His493 General acid-base catalyst
Lys495 Substrate binding and transition state stabilization
Asn516 Substrate binding and transition state stabilization
Ser518 DNA binding
Glu538 Activation of His263
Residues are defined as “conserved” based on a multiple sequence alignment of Tdp1 orthologs from human, S. cerevisiae, S. pombe, D.
melanogaster, C. elegans, and A. thaliana [10] and from BLAST alignments of human Tdp1 with the Tdp1 orthologs from T. brucei (TIGR locus
no. 1F7.245), M. musculus (accession no. XP_127061), and A. gambiae str. PEST (accession no. EAA09907).
The use of vanadate as a versatile phosphate mimic This quaternary complex demonstrates the full po-
has revealed the structures of transition states in mecha- tential of vanadate as a powerful aid in structure deter-
nisms such as ATP hydrolysis by myosin [29] and RNA mination. To our knowledge, the transition state mimic
hydrolysis by the hairpin ribozyme [30]. The complex of for the Tdp1 reaction presented here is the first time
vanadate with Tdp1, peptide, and DNA is an even more that vanadate has been used for the generation of a
comprehensive example of the utility of vanadate as a quaternary complex composed of vanadate plus three
tool for structural investigations. To our knowledge, the distinct components in the context of a biological mol-
Tdp1 structure presented here is the first time that vana- ecule. This use of vanadate is potentially a general
date has been used for the generation of a quaternary method for obtaining structural information about in-
complex composed of vanadate and three additional teractions of phosphoryl transfer enzymes with sub-
distinct components. The quaternary complex of Tdp1 strates that would otherwise be difficult or expensive
with vanadate is also significant in that it provides clues to synthesize or purify. Vanadate may also be useful
to the overall pathway of degradation of topoisomerase as a tool for finding leads in structure-based inhibitor
I-DNA complexes in addition to representing the transi- design for Tdp1 and other enzymes that carry out
tion state for a step in the catalytic reaction. phosphoryl transferring reactions, as it can act as a
covalent anchor capable of accepting a variety of test
ligands.Significance
Tyrosyl-DNA phosphodiesterase (Tdp1) is a DNA re- Experimental Procedures
pair enzyme involved in the repair of stalled topoisom-
erase I-DNA complexes. Tdp1, vanadate, single- Crystallization
Human Tdp1 (	1-148) was purified as described [10]. An 8-amino-stranded DNA, and a topoisomerase I-derived peptide
acid peptide of sequence NH2-Lys-Leu-Asn-Tyr-Leu-Asp-Pro-Arg-self-assemble into a quaternary complex that reveals,
COOH was synthesized by United Biochemical Research (Seattle,in a single glance, the substrate binding mode and the
WA). This peptide corresponds to residues 720–727 of human topo-mechanism of the first catalytic step for the enzyme.
isomerase I and contains the catalytic tyrosine residue, Tyr723. This
Single-stranded DNA is bound in the narrow, positively peptide corresponds to the predicted sequence for the trypsin-
charged groove of the substrate binding cleft, al- resistant peptide moiety of the “12-pep” substrate [10] with the
though uncharged polar side chains are largely re- addition of an N-terminal lysine. The DNA employed was a 6-mer
oligonucleotide of sequence 5-AGAGTT-3 synthesized by Macro-sponsible for specific interactions with the DNA. The
molecular Resources (Fort Collins, CO). The sequence was derivedpeptide moiety is bound in the larger, more open half
from the 3 end of the nucleic acid portion of the “12-pep” substrateof the substrate binding cleft but is held in place with
used for Tdp1 activity assays [10]. Crystallization was carried out
very few specific hydrogen bonds. The trigonal bipyra- by mixing a solution of Tdp1 (5.5 mg/ml), 3 mM sodium orthovana-
midal geometry of the vanadate moiety is consistent date, 5 nmol/
l DNA, and 20 nmol/
l peptide in 1  1 microliter
with the transition state of an SN2 nucleophilic attack sitting drops with a crystallant containing 22% PEG 3350, 100 mM
HEPES (pH 7.8), 200 mM NaCl, and 10 mM spermine. Crystals be-on phosphate, where the tyrosine-containing peptide
longed to space group P212121, had a plate-like habit, and grew tois the leaving group. Remarkably, the conformation of
approximately 0.2  0.1  0.02 mm in 2–4 days. Cell dimensionsthe substrate analog observed in the Tdp1 complex
were a  49.80 A˚, b  104.72 A˚, c  193.92 A˚. Crystals werecannot be achieved without significant rearrangement
stabilized for flash cooling by direct transfer to a cryoprotectant
or degradation of the native topoisomerase I-DNA containing 14% PEG 3000, 375 mM NaCl, 100 mM HEPES (pH 7.8),
complex, consistent with the previous proposal that 28% PEG 250 dimethyl ether, 5 mM sodium orthovanadate, 5 nmol/
additional factor(s) must participate in the Tdp1-medi- 
l DNA, and 20 nmol/
l peptide. After 30–60 s in cryoprotectant,
crystals were flash cooled by direct plunging into liquid nitrogen.ated repair pathway.
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Pommier, Y. (2000). Conversion of topoisomerase I cleavageTable 2. Data Collection and Refinement Statistics for
complexes on the leading strand of ribosomal DNA into 5-Tdp1-Vanadate-DNA-Peptide
phosphorylated DNA double-strand breaks by replication run-
Data Collection off. Mol. Cell. Biol. 20, 3977–3987.
3. Pourquier, P., and Pommier, Y. (2001). Topoisomerase I-medi-
 (A˚) 1.0332
ated DNA damage. Adv. Cancer Res. 80, 189–216.Space group P212121 4. Pommier, Y. (1998). Diversity of DNA topoisomerases I and in-Unit cell dimensions a,b,c (A˚) 49.80, 104.72, 193.92
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5. Pouliot, J.J., Yao, K.C., Robertson, C.A., and Nash, H.A. (1999).Mosaicity () 0.474
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isomerase I complexes. Science 286, 552–555.Completeness (highest shell) (%) 92.6 (61.9)
6. Pouliot, J.J., Robertson, C.A., and Nash, H.A. (2001). PathwaysAverage I/a (highest shell) 18.88 (2.08)
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myces cerevisiae. Genes Cells 6, 677–687.Rsym (%)b 8.5 (33.9) 7. Vance, J.R., and Wilson, T.E. (2002). Yeast Tdp1 and Rad1-
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cative damage. Proc. Natl. Acad. Sci. USA 99, 13669–13674.
Resolution range (A˚) 100–2.3 8. Liu, C., Pouliot, J.J., and Nash, H.A. (2002). Repair of topoisom-
Reflections (free) 38958 (2060) erase I covalent complexes in the absence of the tyrosyl-DNA
Rcrystal (Rfree) (%)c 20.6 (25.2) phosphodiesterase Tdp1. Proc. Natl. Acad. Sci. USA 99, 14970–
Rms deviations from ideality 14975.
Bond lengths (A˚) 0.014 9. Takashima, H., Boerkoel, C.F., John, J., Saifi, G.M., Salih,
Bond angles (degrees) 1.387 M.A.M., Armstrong, D., Mao, Y., Quiocho, F.A., Roa, B.B., Naka-
Chirality 0.096 gawa, M., et al. (2002). Mutation of TDP1, encoding a topoisom-
erase I-dependent DNA damage repair enzyme, in spinocerebel-a I/ is the mean reflection intensity divided by the estimated error.
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